Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Anasetti

Showing results (11-20 of 223) with videos related to

Pageof 23
Sort By:
Current Hematology Reports|July 13, 2005
Selection of unrelated donors for hematopoietic cell transplantationTeresa Field, Claudio Anasetti
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2010
Glucocorticoid-refractory acute graft-versus-host diseaseJoseph Pidala, Claudio Anasetti
Blood|July 9, 2016
Predicting relevant immunogenetic disparitiesJoseph Pidala, Claudio Anasetti
Haematologica|May 13, 2022
Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-<i>versus</i>-host diseaseJoseph Pidala, Claudio Anasetti
The Lancet. Haematology|January 29, 2021
First-line hypomethylating agents for patients with high risk chronic myelomonocytic leukaemiaNelli Bejanyan, Claudio Anasetti
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Role and timing of hematopoietic cell transplantation for myelodysplastic syndromeTeresa Field, Claudio Anasetti
Haematologica|December 18, 2009
Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Joseph Pidala, Claudio Anasetti
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell TransplantationAsmita Mishra, Claudio Anasetti
Transplantation and Cellular Therapy|December 27, 2025
Optimal avidity of the Immune Synapse and mitochondrial repair trigger asymmetrical cell division and CAR T cell persistence - ReviewJyotishankar Raychaudhuri, Claudio Anasetti
The Journal of Clinical Investigation|February 3, 2007
To ablate or not to ablate? HSCs in the T cell driver's seatClaudio Anasetti, James J Mulé
Pageof 23

Showing results (11-20 of 223) with videos related to

Sort By:
Pageof 23
Current Hematology Reports|July 13, 2005
Selection of unrelated donors for hematopoietic cell transplantationTeresa Field, Claudio Anasetti
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2010
Glucocorticoid-refractory acute graft-versus-host diseaseJoseph Pidala, Claudio Anasetti
Blood|July 9, 2016
Predicting relevant immunogenetic disparitiesJoseph Pidala, Claudio Anasetti
Haematologica|May 13, 2022
Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-<i>versus</i>-host diseaseJoseph Pidala, Claudio Anasetti
The Lancet. Haematology|January 29, 2021
First-line hypomethylating agents for patients with high risk chronic myelomonocytic leukaemiaNelli Bejanyan, Claudio Anasetti
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Role and timing of hematopoietic cell transplantation for myelodysplastic syndromeTeresa Field, Claudio Anasetti
Haematologica|December 18, 2009
Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Joseph Pidala, Claudio Anasetti
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell TransplantationAsmita Mishra, Claudio Anasetti
Transplantation and Cellular Therapy|December 27, 2025
Optimal avidity of the Immune Synapse and mitochondrial repair trigger asymmetrical cell division and CAR T cell persistence - ReviewJyotishankar Raychaudhuri, Claudio Anasetti
The Journal of Clinical Investigation|February 3, 2007
To ablate or not to ablate? HSCs in the T cell driver's seatClaudio Anasetti, James J Mulé
Pageof 23